Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN649567

Nuclear Factor-KB P65 (NFkBP65) antibody

Request
Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms C-Rel, Xrel2, c-rel, rel-A, v-rel, xrel, zgc:100833, p65, NFkB
Reactivity
»Alternatives Human
Host
»Alternatives Rabbit
Clonality Monoclonal
Conjugate
»Alternatives Un-conjugated
Application
»Alternatives Western Blotting (WB), Immunoprecipitation (IP)
Pubmed 1 reference available
Catalog no. ABIN649567
Quantity 100 µL
Price
450.00 $   Plus shipping costs $45.00
Shipping to
Availability Will be delivered in 2 to 3 Business Days
Specificity A synthetic peptide corresponding to residues in human c-Rel was used as an immunogen.
Alternative Name c-Rel
Background C-Rel is a member of the nuclear factor kB (NF-kB) transcription factor family. The NF-kB family of dimeric transcription factors consists of four other mammalian members, RelA (p65), RelB, NF-kB1 (p105/p50) and NFkB2 (p100/p52) and is involved in many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. c-Rel is a proto-oncogene that may play a role in differentiation and lymphopoiesis. c-Rel form different dimer combinations that act as transcriptional activators of repressors (1). Findings indicate that RelA and c-Rel control the development of the epidermis and associated appendages during embryogenesis, they regulate epidermal homeostasis in a postnatal environment through the suppression of innate immune-mediated inflammation (2).
Molecular Weight 78 kDA
Gene ID 7490
UniProt Q04864
Research Area Translation Factors, Phospho-specific antibodies, Protein Modifications, Cancer, Transcription Factors, Signaling, Cell Structure
Application Notes The suggested dilution is: WB: ~~ 1:10000~50000 IP: ~~ 1:10~100
Comment

Background: c-Rel is a member of the nuclear factor kB (NF-kB) transcription factor family. The NF-kB family of dimeric transcription factors consists of four other mammalian members, RelA (p65), RelB, NF-kB1 (p105/p50) and NFkB2 (p100/p52) and is involved in many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. c-Rel is a proto-oncogene that may play a role in differentiation and lymphopoiesis. c-Rel form different dimer combinations that act as transcriptional activators of repressors (1). Findings indicate that RelA and c-Rel control the development of the epidermis and associated appendages during embryogenesis, they regulate epidermal homeostasis in a postnatal environment through the suppression of innate immune-mediated inflammation (2).

Restrictions For Research Use only
Format Liquid
Buffer 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Preservative Sodium azide
Storage -20 °C
Storage Comment c-Rel Antibody can be stored at -20°C for up to 12 months from time of receipt.
Expiry Date 12 months
Background publications Gugasyan, Voss, Varigos et al.: "The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms." in: Molecular and cellular biology, Vol. 24, Issue 13, pp. 5733-45, 2004 (PubMed).

Alternatives for antigen "Nuclear Factor-KB P65 (NFkBP65)", type "Antibodies"
Hosts (691), (54), (6), (4), (1)
Reactivities (734), (426), (348), (81), (78), (78), (38), (8), (6), (3), (2), (2), (2), (2), (2), (1)
Applications (553), (267), (248), (189), (110), (104), (100), (31), (17), (14), (13), (7), (5), (4), (3), (2), (2), (1)
Conjugates (16), (11), (10), (10), (10), (10), (10), (10), (10), (10), (10), (2), (1), (1)
Epitopes (47), (43), (43), (42), (31), (31), (29), (28), (27), (22), (18), (15), (12), (7), (6), (6), (6), (4), (4), (4), (4), (3), (3), (3), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Beacon